BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

GC Biopharma Licensed to Build Plasma Fractionation Plant in Indonesia

GC Biopharma, a South Korean biopharmaceutical company, announced on Jun. 1st that it has successfully obtained final approval from the Indonesia...

June 02, 2023 | News

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

June 01, 2023 | News

Lunit and the JNCCHE Partner in AI Pathology to Advance Precision Oncology

Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced collaboration with the National Cancer Center...

May 31, 2023 | News

HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Pharma Collaborate on Parkinson's Therapy

HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a co-developm...

May 26, 2023 | News

Lunit's AI-Biomarker Platform Shows Predictive Value at ASCO 2023

Lunit (KRX:328130.KQ), a global leader of AI-powered cancer diagnostics and therapeutics solutions, is set to make a significant impact at the American Soc...

May 26, 2023 | News

Daewoong Pharmaceutical Reveals Bersiporocin's Antifibrotic Mechanism

Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporo...

May 26, 2023 | News

Avixgen accelerates the progress on new drug pipeline development

DxVx has released development updates on the pipelines of its recently acquired company, Avixgen. DxVx acquired about 63% stake of Avixgen, which is a new ...

May 25, 2023 | News

PharmAbcine's Novel Antibody Approved for Clinical Trial in nAMD

The Phase I clinical trial is an open-label, multi-center, single and multiple ascending-dose study to assess safety, tolerability, MTD (maximum tolerated ...

May 24, 2023 | News

SK Bioscience Proposes Vaccine Access Solution at World Economic Forum's Collaborative

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company's CE...

May 24, 2023 | News

Genome & Company Advances Phase II Trial After Positive Interim Analysis, Proceeds to Second Stage

Genome & Company (CEO: Pae, Jisoo), a global leading microbiome therapeutics developer, announced that this phase II trial (NCT05419362) will continue ...

May 22, 2023 | News

Gencurix Reports Clinical Results of 15-Year Follow-Up Prognostic Test for Cancer Patients in Korea and Japan

Gencurix announced clinical results of its prognostic test for breast cancer patients at the Global Breast Cancer Conference 2023. The study, 'Long-te...

May 10, 2023 | News

MEDICAL IP utilizes NVIDIA Omniverse to develop virtual Medical Digital Twins

MEDIP PRO, a real-time digital twin implementation solution based on medical imaging, is now connected to NVIDIA Omniverse Maximize medical data...

May 09, 2023 | News

Merck to Establish BioProcessing Production Center in South Korea with Ministry and Daejeon City

MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem Proposed bioprocessing facility to be based in Daej...

May 03, 2023 | News

Toshiba's Heavy Ion Therapy System treats patients at Yonsei University Health System.

Toshiba Energy Systems & Solutions Corporation (hereinafter "Toshiba ESS") is pleased to announce today the commencement of treatment using a heavy ion...

April 30, 2023 | News

Stay Connected